Two candidate vaccine the CDC is analyzing contain a mix of genes from the new swine flu virus with components of other viruses that allow them to grow better in the eggs that manufacturers use to produce vaccine.

If one or both prove usable, manufacturers could begin producing pilot lots for testing this summer to see if the shots are safe, trigger immune protection and require one dose or two.